The Asia Pacific Digital Pathology Market is expected to witness market growth of 7.5% CAGR during the forecast period (2020-2026).
Teleconsultation focuses on omitting geographical & functional distances between two or more distant or remotely working healthcare providers. It refers to the consultation by distant telecommunications, principally for the treatment of any patient at sites that are far away from the primary physicians. Currently, Teleconsultation services are being incorporated by many hospitals, mainly private medical practices, healthcare physicians, and other medical entities. Hence, it is determined to be feasible & efficient for decreasing costs, offer organizational advantages, and enhance patient satisfaction.
Owing to the combination of digital pathology with digital tools, specimen tracking, barcoding, and digital dictation that enhance the quality, safety, and efficiency of disease diagnoses in pathology labs, the usage of digital pathology is constantly increasing.
The combination of Artificial Intelligence with digital pathology has offered validation equipment or a supplementary analysis tool for all the pathologists to incorporate image analytics by converting more slides within a certain time. It will assist pathologists to specifically aim at certain areas and enhance the effectiveness of total outcomes. The utilization of artificial intelligence in digital pathology can transform the patient experience with equipment and apps, which provides access to electronic health records, radiology images, etc. enabling the patients to actively take part in the treatment procedure is anticipated to boost the demand for digital pathology solutions throughout the forecast period.
Based on Product, the market is segmented into Device, Software and Storage System. Based on End Use, the market is segmented into Hospitals, Diagnostic Labs, Biotech & pharma companies and Academic & research institutes. Based on Application, the market is segmented into Drug Discovery & Development, Disease Diagnosis and Academic research. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The China market dominated the Asia Pacific Drug Discovery & Development Market by Country in 2019, growing at a CAGR of 5.6 % during the forecast period. The Japan market is experiencing a CAGR of 8.9% during (2020 - 2026). Additionally, The India market is anticipated to witness a CAGR of 8.9% during (2020 - 2026).
The Device market dominated the Malaysia Digital Pathology Market by Product in 2019, thereby, achieving a market value of $8.5 Million by 2026. The Software market is expected to witness a CAGR of 9.4% during (2020 - 2026).
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Danaher Corporation (Leica Biosystems), Koninklijke Philips N.V., Olympus Corporation, F. Hoffmann-La Roche Ltd., ContextVision AB, Hamamatsu Photonics K.K., Mikroscan Technologies, Inc., Inspirata, Inc., Visiopharm A/S, and 3DHISTECH Ltd.
Scope of the Study
Market Segments covered in the Report:
By Product
By End Use
By Application
By Country
Companies Profiled
Unique Offerings from the Publisher
Teleconsultation focuses on omitting geographical & functional distances between two or more distant or remotely working healthcare providers. It refers to the consultation by distant telecommunications, principally for the treatment of any patient at sites that are far away from the primary physicians. Currently, Teleconsultation services are being incorporated by many hospitals, mainly private medical practices, healthcare physicians, and other medical entities. Hence, it is determined to be feasible & efficient for decreasing costs, offer organizational advantages, and enhance patient satisfaction.
Owing to the combination of digital pathology with digital tools, specimen tracking, barcoding, and digital dictation that enhance the quality, safety, and efficiency of disease diagnoses in pathology labs, the usage of digital pathology is constantly increasing.
The combination of Artificial Intelligence with digital pathology has offered validation equipment or a supplementary analysis tool for all the pathologists to incorporate image analytics by converting more slides within a certain time. It will assist pathologists to specifically aim at certain areas and enhance the effectiveness of total outcomes. The utilization of artificial intelligence in digital pathology can transform the patient experience with equipment and apps, which provides access to electronic health records, radiology images, etc. enabling the patients to actively take part in the treatment procedure is anticipated to boost the demand for digital pathology solutions throughout the forecast period.
Based on Product, the market is segmented into Device, Software and Storage System. Based on End Use, the market is segmented into Hospitals, Diagnostic Labs, Biotech & pharma companies and Academic & research institutes. Based on Application, the market is segmented into Drug Discovery & Development, Disease Diagnosis and Academic research. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The China market dominated the Asia Pacific Drug Discovery & Development Market by Country in 2019, growing at a CAGR of 5.6 % during the forecast period. The Japan market is experiencing a CAGR of 8.9% during (2020 - 2026). Additionally, The India market is anticipated to witness a CAGR of 8.9% during (2020 - 2026).
The Device market dominated the Malaysia Digital Pathology Market by Product in 2019, thereby, achieving a market value of $8.5 Million by 2026. The Software market is expected to witness a CAGR of 9.4% during (2020 - 2026).
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Danaher Corporation (Leica Biosystems), Koninklijke Philips N.V., Olympus Corporation, F. Hoffmann-La Roche Ltd., ContextVision AB, Hamamatsu Photonics K.K., Mikroscan Technologies, Inc., Inspirata, Inc., Visiopharm A/S, and 3DHISTECH Ltd.
Scope of the Study
Market Segments covered in the Report:
By Product
- Device
- Software
- Storage System
By End Use
- Hospitals
- Diagnostic Labs
- Biotech & pharma companies
- Academic & research institutes
By Application
- Drug Discovery & Development
- Disease Diagnosis
- Academic research
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Companies Profiled
- Danaher Corporation (Leica Biosystems)
- Koninklijke Philips N.V.
- Olympus Corporation
- F. Hoffmann-La Roche Ltd.
- ContextVision AB
- Hamamatsu Photonics K.K.
- Mikroscan Technologies, Inc.
- Inspirata, Inc.
- Visiopharm A/S
- 3DHISTECH Ltd.
Unique Offerings from the Publisher
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis - Global
Chapter 4. Asia Pacific Digital Pathology Market by Product
Chapter 5. Asia Pacific Digital Pathology Market by End-use
Chapter 6. Asia Pacific Digital Pathology Market by Application
Chapter 7. Asia Pacific Digital Pathology Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Danaher Corporation (Leica Biosystems)
- Koninklijke Philips N.V.
- Olympus Corporation
- F. Hoffmann-La Roche Ltd.
- ContextVision AB
- Hamamatsu Photonics K.K.
- Mikroscan Technologies, Inc.
- Inspirata, Inc.
- Visiopharm A/S
- 3DHISTECH Ltd.
Methodology
LOADING...
